CClinicalTrials.gg
CompletedNCT07110467blinking dryUpdated Aug 7, 2025

Nursing Intervention of Blinking Exercises to Alleviate Dry Eye and Enhance Daily Life in Older Adults

An interventional study of blinking exercises in Daily Activities and Eye Health, sponsored by Norther Private Collage of Nursing. Completed at 1 site in Saudi Arabia. Open to participants aged 60 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-07.

Sponsored by Norther Private Collage of Nursing · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Nov 2024, registered Jul 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
60 Years to 75 Years
Sex
All
01

Study summary

The study aimed to evaluate the effect of blinking exercises in improving eye dryness and daily life in older adults. Participants aged 60 years and older of both genders, diagnosed with dry eyes and patients who were alert and able to communicate.

Read the detailed description

The Research hypotheses include H0: Nursing interventions of blinking exercise do not affect the level of dry eyes and daily life in older adults.

H1: Nursing interventions of blinking exercise affect the level of dry eyes and daily life in older adults.

Participants were divided into two groups (study and control). Both groups were asked to fill out all questionnaires before and after the study using the same tools. In the control group, older adult receives routine care, which was provided by the hospital as examination, application of moisturizing eye drops three- five times Aday for 4 weeks . Participants were asked to answer a post-test using the same pre-test questionnaires. And the study group were divided into small training groups with 3-5 older adult for each group. Two sessions were needed for each group each session took about 1- 2hrs.

02

Conditions studied

  • Daily Activities
  • Eye Health
03

In context

Lead sponsor

Norther Private Collage of Nursing is the lead sponsor of 7 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • aged 60 years and older of both genders, diagnosed with dry eyes and patients who were alert and able to communicate.

Exclusion criteria

Exclusion Criteria:

  • Patients underwent refractive surgery procedures.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    blinking excelsis group

    The study group were divided into small training groups with 3-5 older adult for each group. Two sessions were needed for each group each session took about 1- 2hrs. • The 1st session included (definition, causes, signs \& symptoms, risk factors, complications, prevention, and management of eye dryness and the 2nd session covered the recommended exercises for reducing eye dryness including (Eye gaze exercise, Right and left eye movement exercise, eye rise and fall exercise, eye-crossing exercise, eye control exercise, eye pressure exercise, eye rotation exercise, and eye relaxation exercise). This group was instructed to instill artificial tears and perform blinking exercises three- five times a day for 4 weeks.

    Procedure: blinking exercises

  • Sham comparator
    control group

    this group receive moisturizing eye drop only

    Procedure: blinking exercises

Interventions

  • Procedureblinking exercises

    The study group was instructed to instill artificial tears and perform blinking exercises three- five times a day for 4 weeks.

06

What researchers measure

Primary outcomes

  1. change in quality of life

    Impact Dry Eye Everyday Life Questionnaire it include 3 domains (daily activity limitations, emotional wellbeing, and work limitations), a scale score is calculated between 0 (representing total impairment) and 100 (representing no impairment). The daily activities sub-domain is the quality of life instrument. It is comprised of 27 items, each item had five answers "strongly agree" is scored as 1, "agree" is scored as 2, "neutral" is scored as 3, "disagree" is scored as 4, and "strongly disagree" is scored as 5. The greater score indicate high quality of life.

    Time frame: 4 weeks following the end of treatment

07

Study locations

1 site
  • Norther Private Colleague of Nursing
    Arar, Norther Border 1447, Saudi Arabia
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07110467
Lead sponsor
Norther Private Collage of Nursing
Responsible party
Amal (Associate professor, Norther Private Collage of Nursing) — Principal investigator
First posted
Aug 7, 2025
Start date
Nov 1, 2024
Primary completion
May 2, 2025
Completion
Jun 12, 2025
Last update
Aug 7, 2025

Study contacts

Mostafa Assistance professor, phd
study director · Cairo University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion